Related Experiment Videos

Genotoxicity testing of potassium canrenoate in cultured rat and human cells

A Martelli1, F Mattioli, R Carrozzino

  • 1Department of Internal Medicine, Division of Clinical Pharmacology and Toxicology, University of Genoa, Viale Benedetto XV 2, I-16132 Genoa, Italy.

Mutagenesis
|September 3, 1999
PubMed

Insights

Potassium canrenoate (PC) causes DNA damage and repair in rat and human liver cells, indicating potential genotoxicity. These effects, observed at therapeutic concentrations, are more pronounced in rats than humans.

Area of Science:

  • Toxicology
  • Molecular Biology
  • Genetics

Background:

  • Potassium canrenoate (PC) is an aldosterone antagonist used for hypertension and as a diuretic.
  • Steroids with similar structures have demonstrated genotoxic potential.

Purpose of the Study:

  • To investigate the genotoxic effects of Potassium canrenoate (PC) in cultured rat and human cells.
  • To determine if PC induces DNA damage, DNA repair, and micronucleus formation.

Main Methods:

  • Comet assay for DNA fragmentation.
  • Quantitative autoradiography for DNA repair synthesis.
  • Micronucleus test for chromosomal damage.

Main Results:

  • PC induced dose-dependent DNA fragmentation and repair in rat and human hepatocytes.
  • Effects were more pronounced in rat hepatocytes and in female cells.
  • PC caused micronucleus formation in rat hepatocytes but not in human hepatocytes or lymphocytes.

Conclusions:

  • Hepatocytes activate PC into DNA-damaging species.
  • PC exhibits genotoxic potential at therapeutic concentrations, with higher potency in rats.
  • The structural similarity to other genotoxic steroids warrants caution regarding potential carcinogenic hazards.

Related Concept Videos